Progress in the Application of Marine Polysaccharide Drug Delivery Systems in Tumor Immunotherapy: Multiple Mechanisms and Material Forms
Marine Drugs · 2025
DOI: 10.3390/md23100384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Mingxue Cha und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China. Hauptthemen laut MEDLINE: Polysaccharides, Neoplasms, Immunotherapy, Drug Delivery Systems. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 218 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Project Fund of Marine Biomedical Science and 451 Technology Innovation Platform of Lin-Gang Special Area, the Fund of the 452 Technology Innovation Center for Exploitation of Marine Biological Resources, MNR, Open Project Fund of Marine Biomedical Science and Technology Innovation Platform of Lin-Gang Special Area.
Abstract (Originalsprache)
Tumor immunotherapy, a revolutionary cancer treatment, is hindered by inadequate immune cell activation, immunosuppressive tumor microenvironment (TME), and off-target toxicities of immunotherapeutics. These bottlenecks necessitate innovative strategies to enhance efficacy and reduce side effects. Marine polysaccharides have garnered significant attention due to their potential to enhance immune cell activity and regulate the tumor microenvironment, among other benefits. Due to their excellent biocompatibility, modifiability, and relatively low cost, polysaccharides are increasingly being explored as materials for drug delivery systems. The development of marine polysaccharide-based drug delivery systems represents an opportunity for advancing tumor immunotherapy. This review focuses on the application of marine polysaccharide drug delivery systems in tumor immunotherapy, exploring the mechanisms underlying the bioactivity of marine polysaccharides, the design of drug delivery systems, and the interactions between these systems and tumor immunotherapy, aiming to provide a framework for advancing marine polysaccharide-based therapeutics, accelerating the clinical translation of effective, safe, and targeted tumor immunotherapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
- Technical Innovation Center for Utilization of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005, China.
- Marine Biomedical Science and Technology Innovation Platform of Lin-Gang Special Area, Shanghai 201306, China.
ORCID-Profile: Peipei Wang
Förderung
- Open Project Fund of Marine Biomedical Science and 451 Technology Innovation Platform of Lin-Gang Special Area
- the Fund of the 452 Technology Innovation Center for Exploitation of Marine Biological Resources, MNR
- Open Project Fund of Marine Biomedical Science and Technology Innovation Platform of Lin-Gang Special Area
- Fund of the Technology Innovation Center for Exploitation of Marine Biological Resources, MNR
Zitieren
APA
Cha, M., Yan, S., Zhang, Y., & Wang, P. (2025). Progress in the Application of Marine Polysaccharide Drug Delivery Systems in Tumor Immunotherapy: Multiple Mechanisms and Material Forms. Marine Drugs. https://doi.org/10.3390/md23100384
Vancouver
Cha M, Yan S, Zhang Y, Wang P. Progress in the Application of Marine Polysaccharide Drug Delivery Systems in Tumor Immunotherapy: Multiple Mechanisms and Material Forms. Marine Drugs. 2025. doi:10.3390/md23100384
BibTeX
@article{Cha2025,
author = {Cha, Mingxue and Yan, Shuqiang and Zhang, Yiping and Wang, Peipei},
title = {Progress in the Application of Marine Polysaccharide Drug Delivery Systems in Tumor Immunotherapy: Multiple Mechanisms and Material Forms},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23100384}
}
EUVIMED